Medication info
Cozaar 50 mg (Losartan Potassium)

Cozaar 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Hubist Pharmaceuticals Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201501624 · Approved 2015.03.26 · Insurance code 628800560

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is inadequate, the same dose may be given orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Hubist Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • renal disease in patients with type 2 diabetes
View approved original text

This medication is used for the treatment of hypertension and is particularly effective in preventing and treating renal disease in patients with type 2 diabetes. It helps lower blood pressure to reduce cardiovascular strain and protect kidney function. Therefore, it is effectively used in managing hypertension and renal disease resulting from diabetes.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is inadequate, the same dose may be given orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be immediately discontinued upon confirmation of pregnancy. Women who may become pregnant should not take this medication, and if planning to become pregnant, should consult with a doctor. This medication should not be administered to patients with severely impaired liver function or certain genetic lactose intolerances. Caution should be exercised in patients with excessively low blood pressure or severely diminished kidney function. Elderly patients or those with hyperkalemia should have their serum potassium levels monitored periodically while taking this medication. Various side effects such as myalgia, dizziness, cough, dyspepsia may occur, so any abnormal symptoms should be reported to a physician immediately. Serious allergic reactions like angioedema may also arise; if swelling of the face or lips or difficulty breathing occurs, immediate treatment is necessary. Taking this medication with other antihypertensives or potassium supplements may dangerously increase potassium levels, so consultation with a physician is essential. It is advisable to avoid grapefruit juice while on this medication, and it is recommended to discontinue use at least 24 hours prior to surgery. This medication is not for use in children, especially those under 6 years of age or those with severely impaired kidney function. Dizziness or drowsiness may occur; thus, caution should be exercised when driving or operating machinery. In case of overdose, blood pressure may drop sharply, and immediate medical attention should be sought. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 131 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • indigestion
  • cough
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensitivity reduction
  • reduced libido
  • memory impairment
  • migraine
  • nerve hyperexcitability
  • sensory disturbance
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • alopecia
  • dermatitis
  • dry skin
  • purpura
  • erythema
  • flushing
  • phototoxic reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • ocular burning
  • pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • visual impairment
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urinary tract infection
  • angioedema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythematous skin condition
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extrasystole
  • hypoglycemia
  • increased serum creatinine
  • shock symptoms due to hypotension
  • loss of consciousness due to hypotension
  • dyspnea due to hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it should be kept at room temperature between 1°C and 30°C to maintain its efficacy.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.